Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery

Drug Development and Industrial Pharmacy

Volumn 34, Issue 7, 2008, Pages 692-697

  Kear, Clifford L ^a   Yang, Jing ^a   Godwin, Donald A ^a   Felton, Linda A ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Corticosteroids; Epidermal lipids disruption; Hydroxypropyl cyclodextrin; Skin accumulation; Transdermal permeation

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; HYDROCORTISONE; TRIAMCINOLONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; MOUSE; NONHUMAN; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; BETA-CYCLODEXTRINS; EXCIPIENTS; GLUCOCORTICOIDS; HYDROCORTISONE; MICE; MICE, INBRED HRS; PERMEABILITY; PHASE TRANSITION; SKIN; SKIN ABSORPTION; SOLUBILITY; THERMODYNAMICS; TIME FACTORS; TRANSITION TEMPERATURE; TRIAMCINOLONE;

EID: 46949083945     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701842428     Document Type: Article

References (27)

1. Babu, R. J., & Panditt, J. K. (2004). Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. Int. J. Pharm., 271, 155-165.
2. Benson, H. A. (2000). Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol., 1(4), 217-224.
3. Benson, H. A. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Delivery, 2(1), 23-33.
4. Bentley, M. V., Vianna, R. F., Wilson, S., & Collett, J. H. (1997). Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse. J. Pharm. Pharmacol., 49(4), 397-402.
5. Brown, M. B., Martin, G. P., Jones, S. A., & Akomeah, F. K. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery, 13(3), 175-187.
6. Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005). Cyclodextrins in drug delivery: An updated review. AAPS Pharm. Sci. Tech., 6.
7. Elias, P. M. (2005). Stratum corneum defensive functions: An integrated view. J. Invest. Dermatol., 125(2), 183-200.
8. Felton, L. A., Wiley, C. J., & Godwin, D. A. (2002). Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone. Drug Dev. Ind. Pharm., 28(9), 1117-1124.
9. Felton, L. A., Wiley, C. J., & Godwin, D. A. (2004). Influence of cyclodextrin complexation on the in vivo photoprotective effects of oxybenzone. Drug Dev. Ind. Pharm., 30(1), 95-102.
10. Gloor, M., Bettinger, J., & Gehring, W. (1998). Modification of stratum corneum quality by glycerin-containing external ointments. Hautarzt, 49(1), 6-9.
11. Hikima, T., & Maibach, H. (2006). Skin penetration flux and lag-time of steroids across hydrated and dehydrated human skin in vitro. Biol. Pharm. Bull., 29(11), 2270-2273.
12. Kastin, G., & Bowman, L. (1990). Electrical analysis of fresh, excised human skin: Comparison with frozen skin. Pharm. Res., 7, 1141-1146.
13. Kligman, L. H. (1996). The hairless mouse model for photoaging. Clin. Dermatol., 14(2), 183-195.
14. Legendre, J. Y., Rault, I., Petit, A., Luijten, W., Demuynck, I., Horvath, S., Ginot, Y. M., & Cuine, A. (1995). Effects of β-cyclodextrins on skin: Implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur. J. Pharm. Sci., 3, 311-322.
15. Loftsson, T., & Brewster, M. E. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci., 85(10), 1017-1025.
16. Loftsson, T., Frioriksdottir, H., Thorisdottir, S., Stefansson, E., Siguroardottir, A. M., Guomundsson, O., & Sigthorsson, T. (1994). 2-Hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci., 1, 175-180.
17. Loftsson, T., Jarho, P., Masson, M., & Jarvinen, T. (2005). Cyclodextrins in drug delivery. Expert Opin. Drug Deliv., 2(2), 335-351.
18. Loftsson, T., & Masson, M. (2001). Cyclodextrins in topical drug formulations: Theory and practice. Int. J. Pharm., 225(1-2), 15-30.
19. Moser, K., Kriwet, K., Froehlich, C., Kalia, Y. N., & Guy, R. H. (2001). Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm. Res., 18(7), 1006-1011.
20. Murthy, S. N., Zhao, Y. L., Sen, A., & Hui, S. W. (2004). Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. J. Controlled Release, 99(3), 393-402.
21. Pitman, I., & Downes, L. (1982). Cattle and sheep skin permeability: comparison of frozen and reconstituted skin with that of fresh skin. J. Pharm. Sci., 71, 846.
22. Rawlings, A. V., & Harding, C. R. (2004). Moisturization and skin barrier function. Dermatol Ther., 17 Suppl 1, 43-48.
23. Rowe, R. C., Sheskey, P. J., & Owen, S. C. (2006). Handbook of pharmaceutical excipients (pp. 217-221). London: Pharmaceutical Press.
24. Sznitowska, M., Janicki, S., & Williams, A. C. (1998). Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. J. Pharm. Sci., 87(9), 1109-1114.
25. Vollmer, U., Muller, B. W., Peeters, J., Mesens, J., Wilffert, B., & Peters, T. (1994). A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats. J. Pharm. Pharmacol., 46(1), 19-22.
26. Weigmann, H. J., Jacobi, U., Antoniou, C., Tsikrikas, G. N., Wendel, V., Rapp, C., Gers-Barlag, H., Sterry, W., & Lademann, J. (2005). Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J. Biomed. Opt., 10(1), 14009.
27. Williams, A. C., Shatri, S. R. S., & Barry, B. W. (1998). Transdermal permeation modulation by cyclodextrins: A mechanistic study. Pharm. Dev. Technol., 3(3), 283-296.